Trichoderma species are filamentous fungi that were previously considered to be culture contaminants. We report 2 well-documented cases of invasive Trichoderma infections, and we comprehensively review the literature on this topic. Trichoderma species are mainly responsible for continuous ambulatory peritoneal dialysis-associated peritonitis (7 cases) and invasive infections in immunocompromised patients (9 cases) with a hematologic malignancy or solid-organ transplant. Definitive diagnosis is difficult to achieve because of the lack of specific diagnosis tools. Species identification can benefit from a molecular approach. Trichoderma longibrachiatum is the most common species involved in these infections. Regardless of the type of infection, the prognosis was poor, with 8 deaths among 18 cases. This may be partially because of the resistance of these organisms to the majority of available antifungal agents, including amphotericin B. Trichoderma species now should be added to the growing list of emerging filamentous fungal pathogens.
M A J O R A R T I C L E
Trichoderma species are filamentous fungi that were previously considered to be culture contaminants. We report 2 well-documented cases of invasive Trichoderma infections, and we comprehensively review the literature on this topic. Trichoderma species are mainly responsible for continuous ambulatory peritoneal dialysis-associated peritonitis (7 cases) and invasive infections in immunocompromised patients (9 cases) with a hematologic malignancy or solid-organ transplant. Definitive diagnosis is difficult to achieve because of the lack of specific diagnosis tools. Species identification can benefit from a molecular approach. Trichoderma longibrachiatum is the most common species involved in these infections. Regardless of the type of infection, the prognosis was poor, with 8 deaths among 18 cases. This may be partially because of the resistance of these organisms to the majority of available antifungal agents, including amphotericin B. Trichoderma species now should be added to the growing list of emerging filamentous fungal pathogens.
Trichoderma species are common plant saprophytes and wood-decaying fungi. Allergic manifestations associated with Trichoderma exposure have been reported elsewhere [1] . However, Trichoderma species also appear to belong to the growing list of emergent pathogens, with an increasing number of reports of invasive infections [2, 3] . These infections are characterized by the presence of fine septate hyphae in tissue sections, the so-called "hyalohyphomycosis pathological entity," for which differential diagnosis with invasive aspergillosis is critical. On the basis of 2 well-documented cases and a review of the literature, we describe the main clinical and therapeutic features of these infections. Differential characteristics with invasive aspergillosis and other hyalohyphomycosis are also emphasized.
CASE REPORTS AND METHODS

Case 1.
A 63-year-old woman underwent liver transplantation in August 1997 because she had hepatitis C virus-induced cirrhosis. Immunosuppressive therapy included oral tacrolimus (6 mg q.d.) and prednisolone (20 mg q.d.). The postoperative course was on the whole satisfactory except for persistent pancytopenia of unclear origin. Nine months later, when her WBC count was cells/L (45% polymorphonuclear 6 1700 ϫ 10 cells), the patient presented with abdominal pain in the right-upper quadrant. She had a temperature of 38.5ЊC. Otherwise, the findings of a clinical examination were normal. Biological measurements, including determination of hepatic enzyme levels, did not reveal any abnormality. Abdominal ultrasonography revealed a subcapsular collection ( cm) related to suture 3.5 ϫ 1.5 threads. Examination of the abscess aspirate obtained through a fine needle-transparietal puncture demonstrated numerous fine septate hyphae with regular dichotomy division. Testing for Aspergillus antigenemia by ELISA (Sanofi Diagnostic Pasteur) yielded negative results. Culture of a sample of the pus yielded pure cultures of Trichoderma species (i.e., no microorganism other than Trichoderma species was detected), identified as Trichoderma pseudokoningii on macro-and microscopic examination of the colonies. Similar findings were obtained during a 3-month period from 2 other samples obtained from a scar swabbing and from biopsy specimens of perilesional tissues. The latter revealed a granulomatous hypodermitis containing numerous hyphae noted on periodic acid-Schiff stains, with septa and heterogeneous diameter (figure 1 , and cyclosporine (dosage adapted to achieve a seric assay at 250 mg/mL). Preventive antifungal therapy with oral itraconazole (400 mg q.d.) was also initiated. The patient's postoperative course was immediately complicated by septic shock, which was treated with antibiotics (vancomycin, ceftazidime, tobramycin, and ciprofloxacin) plus amphotericin B lipid complex (3 mg/kg q.d.). Moreover, because of cytomegalovirus antigenemia, the patient received ganciclovir (3 g q.d. iv). Unfortunately, the clinical course did not improve, and the child developed bilateral pulmonary edema. Amphotericin B lipid complex was then replaced by oral itraconazole solution (500 mg b.i.d.). Thoracic tomodensitometry revealed bilateral pneumothorax, pneumopericardium, and a dense lesion of the right apex. On day 14 after transplantation, a sample obtained from the transcutaneous tracheal puncture and a bronchoalveolar lavage fluid sample obtained on the same day tested negative on direct examination, but both samples yielded Trichoderma species on pure culture. Conventional methods (culture plus morphomicroscopic evaluation) identified the isolate as Trichoderma konigii. A new episode of respiratory distress was attributed to acute graft rejection and treated with 3 bolus injections of methylprednisolone (125 mg each) on days 18-20 after transplantation. Two days later, pleural drainage samples became positive for a multidrug-resistant strain of P. aeruginosa and Trichoderma species. Treatment with liposomal amphotericin B was then initiated (5 mg/kg q.d.) in combination with itraconazole at the same dosage. However, the child died of respiratory distress and cerebral complications 26 days after transplantation. A postmortem examination was not performed. Mycological study. To confirm the species identification, 1 isolate from each patient was directly sequenced according to a published protocol [4] , which gives a 650-bp fragment coding for the intergenic transcribed spacers region (including ITS1, ITS2, and the 5.8S rDNA).
These 2 isolates were also tested in vitro against amphotericin B, itraconazole, and voriconazole by a colorimetric microdilution method adapted from the M38-P method proposed by the National Committee for Clinical Laboratory Standards [5, 6] . In brief, antifungal agents were serially diluted 2-fold in 1640 medium supplemented with l-glutamine and 2 ϫ RPMI buffered with 0.165 M of morpholinesulfonic propane acid buffer to achieve final concentrations of 0.125-64 mg/L. Each dilution was dispensed in sterile U-bottom 96-well plates. Inocula were prepared by adjusting spore suspensions to cells/mL in sterile distilled water and then dispensing 4 2 ϫ 10 into each well. The colorimetric reagent Alamar blue (BioScience International) was added to each well. Sterility controls (no inoculum), growth controls (no drug), and a quality control (Candida krusei American Type Culture Collection [ATCC] 6258) were included for each plate. Incubation was done at 35ЊC for 48 h. For determination of MICs, we considered the lowest drug concentration that showed a slight color change from blue to purple for itraconazole and voriconazole and the lowest drug concentration that showed no color change or the first well that remained blue for amphotericin B. This method has been demonstrated to be highly correlated with the M38-P protocol [6] . Literature search. An electronic search was done with use of the key words "Trichoderma" and "human infection" in the PubMed database (http://www.ncbi.nlm.nih.gov) and the Current Contents Clinical Medicine database (http://www.isinet. com/isi/products/cc/editions/cccm/).
RESULTS
Literature review.
In a comprehensive search, we found 16 well-documented published cases of invasive Trichoderma infection [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . Also, there were 2 cases of keratitis (A. M. Le Flohic, personal communication) [23] . The clinical characteristics are shown in table 1. Moreover, Kulhs et al. [24] and Walsh et al. [25] cite 8 and 1 additional cases, respectively, but because of their lack of clinical details, these cases were not included in the present review. One case of superficial infection (otitis externa) [26] and a case of pulmonary fungus ball [27] , which corresponded to a saprophitism state of the fungus, were also excluded from the present review.
Clinical manifestations. The first case was described in 1969 [19] , but 17 of the 20 reviewed cases were reported during the 1990s. There were 7 cases of peritonitis, all complicating continuous ambulatory peritoneal dialysis (CAPD) (table 1). A previous history of bacterial peritonitis was noted for 5 of 7 patients, but Trichoderma species were always isolated on pure culture. The clinical impact ranged from mild (abdominal discomfort) to more severe (bowel obstruction). Fever was noted in 2 of 5 documented patients. No clinical symptoms could suggest a fungal origin rather than a bacterial origin. Treatment included removal of the dialysis catheter in 5 cases, and antifungal therapy was also provided in 4 of these cases. In 2 cases, antifungal drugs were prescribed without withdrawal of the catheter, but this did not result in recovery [13, 22] . Despite these treatments, 4 patients died, у2 of whom still had progressive fungal infection, as documented by positive culture results after death [9, 15] .
Opportunistic infections complicated the course of hematologic malignancy in 4 patients and solid-organ transplantation in 5 patients (table 1). Infection occurred in 3 patients while they were receiving treatment with antifungal drug(s). In 6 cases, the upper (sinusitis, in 2 patients) or lower airways (pulmonary infections, in 4) were involved without clinical specificity. In 3 cases, the infection was disseminated (у2 noncontiguous organs involved), as documented by postmortem examination. In these cases, there was brain involvement, which presented as a mass-expanding syndrome in 1 case [12] . In another case, the brain abscess corresponded to a contiguous infection from an ethmoidal invasive sinusitis [21] . Skin lesions (ulceronecrotic) were seen in 3 patients; in 2 of these patients, the lesions were at the site of insertion of an intravenous catheter [11, 18] . Five of these patients died, despite administration of antifungal therapy.
Among the miscellaneous cases (table 1) , there were 2 cases of keratitis in subtropical countries (India and Mali) (A. M. Le Flohic, personal communication) [23] and 1 case of postsurgical endocarditis [8] . The original case described by Robertson [19] corresponded to an accidental intravenous infusion of contaminated fluid.
Causative species and in vitro susceptibility testing. Molecular analysis of the 2 isolates recovered from our patients revealed a 100% identity with Trichoderma longibrachiatum (GenBank accession number Z48935) for both isolates. In the aforementioned cases, species identification relied on morphology, sometimes completed by molecular identification. T. longibrachiatum was the most common species, being identified in 8 cases. Seven of the 8 cases cited by Kulhs et al. [24] were also due to T. longibrachiatum. In 4 cases, the identification to the species level was not performed.
Our isolates had MICs of amphotericin of 1 and 2 mg/L, an MIC of itraconazole of 16 mg/L, and an MIC of voriconazole of 2 mg/L. Although the methods used for in vitro susceptibility testing differed widely from one report to another, tested clinical isolates clearly exhibited resistance to fluconazole and flucytosine, frequently exhibited resistance to itraconazole, and exhibited slight susceptibility to amphotericin B (MIC, у1 mg/L).
DISCUSSION
On the basis of a review of the literature, Trichoderma infections in humans appear to be rare, including cases of CAPD-related peritonitis [28] [29] [30] , but they are increasingly being reported, with 85% of the cases being reported the past 10 years. This increase probably reflects the opportunistic behavior of these fungi, favored by the increasing number of immunocompromised patients and the increasing attention of microbiologists to these fungi that were previously considered to be nonpathogenic.
It is important to understand the sources of contamination and routes of infection to adapt preventive measures. Considering the clinical forms (i.e., sinusitis, pneumonia, and abscess following surgery), ambient air is the likely source of infection for some opportunistic infections. This contamination may be enhanced from water-related sites, because Trichoderma species were found to be the most prevalent fungus, after A. fumigatus, among filamentous fungi cultured from samples from outlets, waste pipes, and shower heads in a bone marrow transplantation ward [31] . Trichoderma species have also been isolated from food [32] , and contaminated food may explain the digestive involvement described in a patient who had a positive stool culture result [16] . As demonstrated for Fusarium infections [33] , the catheter may be a portal of entry for invasive Trichoderma infections [11, 16] and CAPD-related infections. Finally, contaminated infusion product can lead to disseminated infection when infused intravenously [19] . This can also be hypothesized as a source of infection for some CAPDrelated cases, as has already been mentioned for infections due to yeasts and other filamentous fungi, such as Aspergillus species [34, 35] .
Definitive diagnosis of Trichoderma infection may be difficult to make, because, as is the case for the diagnosis of other hyalohyphomycosis, it requires the demonstration of hyphae in tissue sections. Culture of blood samples does not appear to be a valuable diagnostic tool, because, despite documented dissemination, there is only 1 report of positive blood culture results for Trichoderma species cited by Kuhls et al. [24] , in addition to the accidental case described by Robertson [19] . This is similar to invasive aspergillosis but contrasts with disseminated Fusarium infections, for which blood culture results are positive in ∼50% of cases [36, 37] . Thus, diagnosis frequently relies on the demonstration of hyphae associated with positive culture results in nonbiopsy specimens obtained from accessible sites (e.g., skin and upper and lower airways) and, more rarely, from urine. The repeated isolation of the same fungus-if possible, from different sites-reinforces this highly probable diagnosis for immunocompromised patients. On direct examination, Trichoderma infection can be misdiagnosed as aspergillosis and other hyalohyphomycosis, because the hyphae are morphologically quite similar. Recently, Guarro et al. [12] emphasized the complexity of the branching pattern of Trichoderma hyphae in tissue. Figure 1 also demonstrates a feature suggestive of an adventitious conidiogenesis, a phenomenon already demonstrated for Fusarium, Acremonium, and Paecilomyces species in cases of invasive infection [38] . Nonculture methods have rarely been used for the diagnosis of Trichoderma infection. Gautheret et al. [11] mentioned antigen detection by use of a kit for the detection of the Aspergillus galactomannan antigen, a result not found in our cases. Einsele et al. [39] , in describing primers for the detection of DNA from numerous pathogenic fungi in serum or blood, did not test Trichoderma in their report. We found that their primers amplified the target sequence on DNA extracted from our 2 stains (data not shown). Thus, their protocol could be tested for Trichoderma DNA detection in patients supposed to be infected with Trichoderma species. The identification of Trichoderma isolates at the species level may be difficult in the case of a positive result, as demonstrated in some reports in which identification that relied only on conventional methods led to erroneous species identification [11, 24, 40] . With use of molecular tools, Kulhs et al. [24] showed that most Trichoderma infections in humans are due to T. longibrachiatum and, more rarely, to Trichoderma citrinoviride [24] . Our cases and a previous case of otitis externa concur with this idea [26] .
Regardless of the clinical presentation, the prognosis of these infections was poor. In patients with CAPD-related infections, recovery occurred in association with removal of the catheter alone in 1 case [20] . Nevertheless, the role of antifungal therapy in the management of these infections should not be underestimated, because persistent infections have been documented despite the removal of the catheter [9, 15] . It is difficult to determine optimal therapeutic management from these observations, but, while not scientifically demonstrated, it seems reasonable to remove the catheter concomitantly with the prescription of an antifungal drug. The latter should be defined according to susceptibility (see below) and pharmacokinetics of the drugs, notably peritoneal diffusion. Five of 9 patients with cancer-associated infection died, among whom у4 had a persistent fungal infection (table 2) . There is a trend showing that disseminated forms had a poor prognosis: all 3 patients with disseminated infection died, whereas there were 2 deaths among 6 patients with localized infections, a clinical feature already reported with invasive fusariosis [36] . Once again, no therapeutic regimen has clearly demonstrated its superiority over the others. Although correlation between in vitro test results and clinical response remains difficult to interpret, the clinical failures may be partly due to the low susceptibility of these fungi to both amphotericin B and available azole derivatives. Even if breakpoints have not yet been defined for these uncommon fungi, isolates recovered from our patients as well as from patients with previous cases exhibited, regardless of the species tested and the method of evaluation used, high MICs against amphotericin B (у1 mg/L), flucytosine (164 mg/L), and available azole derivatives, including itraconazole (у4 mg/L). More recently, voriconazole and Sch56592, new triazole antifungal agents, have been shown to be effective in vitro against filamentous fungi, including a strain of Trichoderma with an MIC of voriconazole of 0.25 mg/L [41, 42] . Our results, although slightly more elevated, warrant further investigations of clinical efficacy of voriconazole in case of Trichoderma infection.
